My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 471

    1.

    ACE inhibitors improve diabetic nephropathy through suppression of renal MCP-1.

    Amann B, Tinzmann R, Angelkort B.

    Diabetes Care. 2003 Aug;26(8):2421-5.PMID: 12882873 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    The effects of dual blockade of the renin-angiotensin system on urinary protein and transforming growth factor-beta excretion in 2 groups of patients with IgA and diabetic nephropathy.

    Song JH, Lee SW, Suh JH, Kim ES, Hong SB, Kim KA, Kim MJ.

    Clin Nephrol. 2003 Nov;60(5):318-26.PMID: 14640237 [PubMed - indexed for MEDLINE]Related articles

    3.

    Effects of dual blockade of the renin-angiotensin system in primary proteinuric nephropathies.

    Luño J, Barrio V, Goicoechea MA, González C, de Vinuesa SG, Gómez F, Bernis C, Espinosa M, Ahijado F, Gómez J, Escalada P.

    Kidney Int Suppl. 2002 Dec;(82):S47-52.PMID: 12410855 [PubMed - indexed for MEDLINE]Related articles

    4.

    Effect of low-dose dual blockade of renin-angiotensin system on urinary TGF-beta in type 2 diabetic patients with advanced kidney disease.

    Song JH, Cha SH, Lee HJ, Lee SW, Park GH, Lee SW, Kim MJ.

    Nephrol Dial Transplant. 2006 Mar;21(3):683-9. Epub 2005 Dec 5.PMID: 16330466 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Effects of dual blockade of renin-angiotensin system in type 2 diabetes mellitus patients with diabetic nephropathy.

    Krairittichai U, Chaisuvannarat V.

    J Med Assoc Thai. 2009 May;92(5):611-7.PMID: 19459520 [PubMed - indexed for MEDLINE]Related articles

    6.

    Effects of dual blockade of the renin angiotensin system in hypertensive type 2 diabetic patients with nephropathy.

    Matos JP, de Lourdes Rodrigues M, Ismerim VL, Boasquevisque EM, Genelhu V, Francischetti EA.

    Clin Nephrol. 2005 Sep;64(3):180-9.PMID: 16175942 [PubMed - indexed for MEDLINE]Related articles

    7.

    Design of combination angiotensin receptor blocker and angiotensin-converting enzyme inhibitor for treatment of diabetic nephropathy (VA NEPHRON-D).

    Fried LF, Duckworth W, Zhang JH, O'Connor T, Brophy M, Emanuele N, Huang GD, McCullough PA, Palevsky PM, Seliger S, Warren SR, Peduzzi P; VA NEPHRON-D Investigators.

    Clin J Am Soc Nephrol. 2009 Feb;4(2):361-8. Epub 2008 Dec 31.PMID: 19118120 [PubMed - indexed for MEDLINE]Related articles

    8.

    Single versus dual blockade of the renin-angiotensin system (angiotensin-converting enzyme inhibitors and/or angiotensin II receptor blockers) in diabetic nephropathy.

    Jacobsen P, Rossing K, Parving HH.

    Curr Opin Nephrol Hypertens. 2004 May;13(3):319-24. Review.PMID: 15073491 [PubMed - indexed for MEDLINE]Related articles

    9.

    Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy.

    Andersen S, Tarnow L, Rossing P, Hansen BV, Parving HH.

    Kidney Int. 2000 Feb;57(2):601-6.PMID: 10652037 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Effect of retinoic acid in experimental diabetic nephropathy.

    Han SY, So GA, Jee YH, Han KH, Kang YS, Kim HK, Kang SW, Han DS, Han JY, Cha DR.

    Immunol Cell Biol. 2004 Dec;82(6):568-76.PMID: 15550114 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Add-on anti-TGF-beta antibody to ACE inhibitor arrests progressive diabetic nephropathy in the rat.

    Benigni A, Zoja C, Corna D, Zatelli C, Conti S, Campana M, Gagliardini E, Rottoli D, Zanchi C, Abbate M, Ledbetter S, Remuzzi G.

    J Am Soc Nephrol. 2003 Jul;14(7):1816-24.PMID: 12819241 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Emerging trends for prevention and treatment of diabetic nephropathy: blockade of the RAAS and BP control.

    Hunsicker LG.

    J Manag Care Pharm. 2004 Sep;10(5 Suppl A):S12-7. Review.PMID: 15369420 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Association of monocyte chemoattractant protein-1 with renal tubular damage in diabetic nephropathy.

    Morii T, Fujita H, Narita T, Shimotomai T, Fujishima H, Yoshioka N, Imai H, Kakei M, Ito S.

    J Diabetes Complications. 2003 Jan-Feb;17(1):11-5.PMID: 12505750 [PubMed - indexed for MEDLINE]Related articles

    14.

    Clinical significance and different levels of urinary monocyte chemoattractant protein-1 in type 2 diabetes mellitus.

    Wang QY, Chen FQ.

    Diabetes Res Clin Pract. 2009 Feb;83(2):215-9. Epub 2008 Dec 20.PMID: 19097668 [PubMed - indexed for MEDLINE]Related articles

    15.

    Eicosapentaenoic acid ameliorates diabetic nephropathy of type 2 diabetic KKAy/Ta mice: involvement of MCP-1 suppression and decreased ERK1/2 and p38 phosphorylation.

    Hagiwara S, Makita Y, Gu L, Tanimoto M, Zhang M, Nakamura S, Kaneko S, Itoh T, Gohda T, Horikoshi S, Tomino Y.

    Nephrol Dial Transplant. 2006 Mar;21(3):605-15. Epub 2005 Nov 10.PMID: 16282336 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL.

    de Zeeuw D, Remuzzi G, Parving HH, Keane WF, Zhang Z, Shahinfar S, Snapinn S, Cooper ME, Mitch WE, Brenner BM.

    Kidney Int. 2004 Jun;65(6):2309-20.PMID: 15149345 [PubMed - indexed for MEDLINE]Related articles

    17.

    Effect of intensive blood pressure control on the course of type 1 diabetic nephropathy. Collaborative Study Group.

    Lewis JB, Berl T, Bain RP, Rohde RD, Lewis EJ.

    Am J Kidney Dis. 1999 Nov;34(5):809-17.PMID: 10561135 [PubMed - indexed for MEDLINE]Related articles

    18.

    Outcome survey in unselected hypertensive patients with type 2 diabetes mellitus: effects of ACE inhibition.

    Veelken R, Delles C, Hilgers KF, Schmieder RE.

    Am J Hypertens. 2001 Jul;14(7 Pt 1):672-8.PMID: 11465652 [PubMed - indexed for MEDLINE]Related articles

    19.

    Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat.

    Erman A, Veksler S, Gafter U, Boner G, Wittenberg C, van Dijk DJ.

    J Renin Angiotensin Aldosterone Syst. 2004 Sep;5(3):146-51.PMID: 15526251 [PubMed - indexed for MEDLINE]Related articles

    20.

    Increased urinary excretion of monocyte chemoattractant protein-1 in proteinuric renal diseases.

    Morii T, Fujita H, Narita T, Koshimura J, Shimotomai T, Fujishima H, Yoshioka N, Imai H, Kakei M, Ito S.

    Ren Fail. 2003 May;25(3):439-44.PMID: 12803507 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity